Ute Galm

1.5k total citations
19 papers, 1.2k citations indexed

About

Ute Galm is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Ute Galm has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Ute Galm's work include Microbial Natural Products and Biosynthesis (14 papers), Cancer therapeutics and mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ute Galm is often cited by papers focused on Microbial Natural Products and Biosynthesis (14 papers), Cancer therapeutics and mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Ute Galm collaborates with scholars based in United States, Germany and Switzerland. Ute Galm's co-authors include Ben Shen, Jianhua Ju, Martin H. Hager, Jon S. Thorson, Steven G. Van Lanen, Lutz Heide, Meifeng Tao, Jane M. Coughlin, Evelyn Wendt-Pienkowski and Thomas C. Sparks and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Ute Galm

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute Galm United States 15 685 548 460 144 96 19 1.2k
Zixin Deng China 24 1.0k 1.5× 807 1.5× 343 0.7× 235 1.6× 49 0.5× 84 1.5k
Chang‐Ji Zheng China 26 500 0.7× 323 0.6× 1.1k 2.4× 93 0.6× 75 0.8× 54 1.7k
Leah B. Bushin United States 15 799 1.2× 583 1.1× 234 0.5× 138 1.0× 86 0.9× 18 1.1k
D. Srinivasa Reddy India 21 562 0.8× 265 0.5× 1.2k 2.5× 156 1.1× 55 0.6× 111 1.8k
Sébastien Combes France 20 496 0.7× 229 0.4× 814 1.8× 54 0.4× 80 0.8× 46 1.7k
Michio Kurosu United States 26 1.0k 1.5× 363 0.7× 1.0k 2.2× 206 1.4× 105 1.1× 85 2.1k
Zachary D. Aron United States 20 469 0.7× 299 0.5× 676 1.5× 100 0.7× 47 0.5× 30 1.2k
Jarmo Niemi Finland 25 979 1.4× 860 1.6× 348 0.8× 213 1.5× 50 0.5× 51 1.4k
Nigel D. Priestley United States 23 650 0.9× 426 0.8× 396 0.9× 92 0.6× 61 0.6× 48 1.2k
Shumpei Asamizu Japan 21 688 1.0× 717 1.3× 281 0.6× 305 2.1× 50 0.5× 53 1.2k

Countries citing papers authored by Ute Galm

Since Specialization
Citations

This map shows the geographic impact of Ute Galm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Galm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Galm more than expected).

Fields of papers citing papers by Ute Galm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Galm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Galm. The network helps show where Ute Galm may publish in the future.

Co-authorship network of co-authors of Ute Galm

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Galm. A scholar is included among the top collaborators of Ute Galm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Galm. Ute Galm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Galm, Ute & Thomas C. Sparks. (2015). Natural product derived insecticides: discovery and development of spinetoram. Journal of Industrial Microbiology & Biotechnology. 43(2-3). 185–193. 61 indexed citations
2.
Coughlin, Jane M., Jeffrey D. Rudolf, Evelyn Wendt-Pienkowski, et al.. (2014). BlmB and TlmB Provide Resistance to the Bleomycin Family of Antitumor Antibiotics by N-Acetylating Metal-Free Bleomycin, Tallysomycin, Phleomycin, and Zorbamycin. Biochemistry. 53(44). 6901–6909. 9 indexed citations
3.
Huang, Sheng‐Xiong, Zhiyang Feng, Liyan Wang, et al.. (2012). A Designer Bleomycin with Significantly Improved DNA Cleavage Activity. Journal of the American Chemical Society. 134(32). 13501–13509. 37 indexed citations
4.
Galm, Ute, Evelyn Wendt-Pienkowski, Liyan Wang, et al.. (2011). Comparative Analysis of the Biosynthetic Gene Clusters and Pathways for Three Structurally Related Antitumor Antibiotics: Bleomycin, Tallysomycin, and Zorbamycin. Journal of Natural Products. 74(3). 526–536. 52 indexed citations
5.
Tao, Meifeng, Liyan Wang, Evelyn Wendt-Pienkowski, et al.. (2009). Functional characterization of tlmH in Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insight into tallysomycinbiosynthesis and affording a novel bleomycin analog. Molecular BioSystems. 6(2). 349–356. 18 indexed citations
6.
Wang, Liyan, et al.. (2009). Functional Characterization of tlmK Unveiling Unstable Carbinolamide Intermediates in the Tallysomycin Biosynthetic Pathway. Journal of Biological Chemistry. 284(13). 8256–8264. 7 indexed citations
7.
Galm, Ute, Evelyn Wendt-Pienkowski, Nicholas P. George, et al.. (2008). The biosynthetic genecluster of zorbamycin, a member of the bleomycin family of antitumor antibiotics, from Streptomyces flavoviridis ATCC 21892. Molecular BioSystems. 5(1). 77–90. 47 indexed citations
8.
Galm, Ute, Liyan Wang, Evelyn Wendt-Pienkowski, et al.. (2008). In Vivo Manipulation of the Bleomycin Biosynthetic Gene Cluster in Streptomyces verticillus ATCC15003 Revealing New Insights into Its Biosynthetic Pathway. Journal of Biological Chemistry. 283(42). 28236–28245. 35 indexed citations
9.
Galm, Ute & Ben Shen. (2007). Natural Product Drug Discovery: The Times Have Never Been Better. Chemistry & Biology. 14(10). 1098–1104. 51 indexed citations
10.
Wang, Liyan, Bong‐Sik Yun, Nicholas P. George, et al.. (2007). Glycopeptide Antitumor Antibiotic Zorbamycin from Streptomyces flavoviridis ATCC 21892:  Strain Improvement and Structure Elucidation. Journal of Natural Products. 70(3). 402–406. 38 indexed citations
11.
12.
Galm, Ute & Ben Shen. (2006). Expression of biosynthetic gene clusters in heterologous hosts for natural product production and combinatorial biosynthesis. Expert Opinion on Drug Discovery. 1(5). 409–437. 49 indexed citations
13.
Galm, Ute, Martin H. Hager, Steven G. Van Lanen, et al.. (2005). Antitumor Antibiotics:  Bleomycin, Enediynes, and Mitomycin. Chemical Reviews. 105(2). 739–758. 475 indexed citations
14.
Eustáquio, Alessandra S., Bertolt Gust, Ute Galm, et al.. (2005). Heterologous Expression of Novobiocin and Clorobiocin Biosynthetic Gene Clusters. Applied and Environmental Microbiology. 71(5). 2452–2459. 85 indexed citations
15.
Galm, Ute, Martin H. Hager, Steven G. Van Lanen, et al.. (2005). Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin. ChemInform. 36(24). 2 indexed citations
16.
Galm, Ute, Marco A. Dessoy, Jürgen Schmidt, Ludger A. Wessjohann, & Lutz Heide. (2004). In Vitro and In Vivo Production of New Aminocoumarins by a Combined Biochemical, Genetic, and Synthetic Approach. Chemistry & Biology. 11(2). 173–183. 59 indexed citations
17.
Galm, Ute, et al.. (2004). New Aminocoumarin Antibiotics from a cloQ-Defective Mutant of the Chorobiocin Producer Streptomyces reseochromogenes DS12.976. The Journal of Antibiotics. 57(3). 205–209. 8 indexed citations
18.
Galm, Ute, et al.. (2004). Antimicrobial and DNA Gyrase-Inhibitory Activities of Novel Clorobiocin Derivatives Produced by Mutasynthesis. Antimicrobial Agents and Chemotherapy. 48(4). 1307–1312. 79 indexed citations
19.
Galm, Ute, Judith Schimana, Hans‐Peter Fiedler, et al.. (2002). Cloning and analysis of the simocyclinone biosynthetic gene cluster of Streptomyces antibioticus Tü 6040. Archives of Microbiology. 178(2). 102–114. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026